Acadia Pharmaceuticals reported $-43871000 in Net Income for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Acadia Pharmaceuticals ACAD:US $ -43.87M 22.58M
Alexion Pharmaceuticals ALXN:US $ 636M 100.2M
Alnylam Pharmaceuticals ALNY:US $ -189.56M 10.73M
Aptinyx Inc APTX:US $ -19819000 5.59M
Arena Pharmaceuticals ARNA:US $ -146.1M 27.68M
Biogen BIIB:US $ 448.5M 38.3M
Biomarin Pharmaceutical BMRN:US $ 12.94M 4.43M
Bristol Myers Squibb BMY:US $ 1055M 966M
Cara Therapeutics CARA:US $ -30745000 7.44M
Corcept Therapeutics CORT:US $ 26.52M 3.06M
Cytokinetics CYTK:US $ -61.55M 14.45M
Eisai 4523:JP Y 42162M 45209M
Eli Lilly And LLY:US $ 1390.2M 34.9M
Gw Pharmaceuticals GWPH:US $ -19.68M 9.47M
Intercept Pharmaceuticals ICPT:US $ -11.09M 29.33M
Intra Cellular Therapies ITCI:US $ -68.74M 16M
Johnson & Johnson JNJ:US $ 6278M 81M
Marinus Pharmaceuticals MRNS:US $ -23.82M 3.32M
Moderna Inc MRNA:US 2.78B 1.56B
Neurocrine Biosciences NBIX:US $ 42.3M 10.2M
Pfizer PFE:US $ 5564M 686M
Prothena PRTA:US $ 27.64M 64.38M
Ptc Therapeutics PTCT:US $ -118.37M 10.27M
Sarepta Therapeutics SRPT:US $ -81.4M 85.84M
Seattle Genetics SGEN:US $ -84.58M 36.84M
Ultragenyx Pharmaceutical RARE:US $ -122.43M 13.71M
Vanda Pharmaceuticals VNDA:US $ 9.65M 1M
Vertex Pharmaceuticals VRTX:US $ 66.92M 586.21M
YTE INCY:US $ 149.46M 95.92M
Zogenix ZGNX:US $ -58.9M 3.27M